Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL8433562 | 1.00 | — | — | |
| Lithium Ion SCHEMBL395589 | 0.86 | — | — | |
| SCHEMBL31511971 | 0.86 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL1750165 | 0.86 | — | — | |
| SCHEMBL639786 | 0.86 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL1207561 | 0.86 | ALDH1A1 (0.30) | ALDH1A1 | |
| Lithium Ion SCHEMBL318795 | 0.86 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL9304336 | 0.86 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL9641891 | 0.86 | ALDH1A1 (0.30) | ALDH1A1 | |
| Zinc Ion SCHEMBL917737 | 0.86 | ALDH1A1 (0.30) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121574120-A | Oraglycone Process for the preparation of intermediates | 杭州诺澳生物医药科技有限公司 | 2026-02-27 | — | — | CN | claimed |
| WO-2022156784-A1 | PREPARATION METHOD FOR HETEROCYCLIC COMPOUND, AND INTERMEDIATE OF HETEROCYCLIC COMPOUND | 武汉人福创新药物研发中心有限公司 | 2022-07-28 | — | — | WO | claimed |
| WO-2022156783-A1 | PREPARATION METHOD FOR IMIDAZOPYRIDINE COMPOUND AND INTERMEDIATE THEREOF | 武汉人福创新药物研发中心有限公司 | 2022-07-28 | — | — | WO | claimed |
| WO-2022095823-A1 | FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF | 华东师范大学 | 2022-05-12 | — | — | WO | claimed |
| US-6034247-A | REACTIG A UNSATURSATED CARBOXYLATED AMINE WITH A BASE; CYCLIZATION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2000-03-07 | — | — | US | claimed |
| CN-116529417-B | Novel compound, precursor composition comprising same, and method for producing thin film using same | 韩松化学株式会社 | 2026-05-15 | — | — | CN | disclosed |
| CN-118459372-A | Preparation method of photoacid generator sulfonate for ARF photoresist | 常州朗芯新材料科技有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-117700387-A | Rockwell-like alcohol compound, intermediate, preparation method and application | 深圳湾实验室 | 2024-03-15 | — | — | CN | disclosed |
| CN-113912577-B | Rockwell intermediate, rockwell and its derivative, and preparation and application | 深圳湾实验室 | 2023-12-29 | — | — | CN | disclosed |
| CN-116529417-A | Novel compound, precursor composition comprising same, and method for producing thin film using same | 韩松化学株式会社 | 2023-08-01 | — | — | CN | disclosed |
| WO-2022095823-A1 | FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF | 华东师范大学 | 2022-05-12 | — | — | WO | disclosed |
| US-20200392135-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2020-12-17 | — | — | US | disclosed |
| EP-0662481-A1 | Spiro piperidines and homologs promote release of growth hormone | MERCK & CO. INC. (US) | 1995-07-12 | — | — | EP | disclosed |
| US-5371215-A | 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them | AMERICAN CYANAMID COMPANY (US) | 1994-12-06 | — | — | US | disclosed |
| WO-1994019367-A1 | SPIRO PIPERIDINES AND HOMOLOGS PROMOTE RELEASE OF GROWTH HORMONE | MERCK & CO., INC. (US) | 1994-09-01 | — | — | WO | disclosed |
| US-5189158-A | 4-SUBSTITUTED AZETIDINONES AS PRECURSORS TO 2-SUBSTITUTED-3-CARBOXY CARBAPENEM ANTIBIOTICS AND A METHOD OF PRODUCING THEM | AMERICAN CYANAMID COMPANY (US) | 1993-02-23 | — | — | US | disclosed |
| EP-0504612-A2 | Novel 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them | AMERICAN CYANAMID COMPANY (US) | 1992-09-23 | — | — | EP | disclosed |
| US-5145855-A | Hypotensive, memory deficit, asthma, psorisis | HOECHST ROUSSEL PHARMACEUTICALS, INC. (US) | 1992-09-08 | — | — | US | disclosed |
| US-5093336-A | Treatment of cardiac failure and memory deficit | HOECHAT-ROUSSEL PHARMACEUTICALS, INC. (US) | 1992-03-03 | — | — | US | disclosed |
| EP-0406789-A1 | 6-and 7-Deoxyforskolin and derivates thereof, intermediates and a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200392135-A1 | ORGANIC COMPOUNDS | HTR2C, HTR2A, HTR3A | ALDH1A1 1117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.